Skip to main content
Premium Trial:

Request an Annual Quote

Boosts Requested

In a new budget proposal, President Joe Biden is seeking $1.5 trillion in federal spending, which includes a nearly 24 percent funding boost for the US Department of Health and Human Services, the Washington Post reports.

In particular, President Biden's budget request seeks $131.7 billion for HHS, which includes $8.7 billion for the Centers for Disease Control and Prevention, the Post adds. Further, Science reports that the proposal seeks $51 billion for the National Institutes of Health — a boost of $9 billion — and $10.2 billion for the National Science Foundation — an increase of $1.7 billion.

According to Science, the proposed NIH budget includes $6.5 billion for the creation of a new health agency in the mold of the Defense Advanced Research Projects Agency — dubbed ARPA-H — to tackle riskier projects aimed at developing treatments for cancer and conditions like diabetes and Alzheimer's disease.

As Vox notes, the funding request is not a full budget proposal, but does provide a glimpse into Biden Administration priorities. The Post notes that it "stands in stark contrast to Trump's spending goals." The Trump Administration typically sought to cut science and research spending, though Congress did not enact those cuts.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.